JK Agri Genetics Ltd
₹ 314
-0.13%
02 Apr
4:01 p.m.
About
Incorporated in 1989, JK Agri Genetics Ltd
is in the business of Agri & Allied product[1]
Key Points
- Market Cap ₹ 146 Cr.
- Current Price ₹ 314
- High / Low ₹ 577 / 282
- Stock P/E 103
- Book Value ₹ 247
- Dividend Yield 0.00 %
- ROCE -7.09 %
- ROE -13.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -2.11% over past five years.
- Company has a low return on equity of -12.6% over last 3 years.
- Earnings include an other income of Rs.7.54 Cr.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 185 | 205 | 186 | 191 | 202 | 191 | 180 | 224 | 246 | 201 | 148 | 162 | 162 | |
| 159 | 174 | 163 | 165 | 175 | 174 | 184 | 203 | 231 | 209 | 173 | 172 | 159 | |
| Operating Profit | 27 | 31 | 23 | 26 | 27 | 17 | -4 | 21 | 15 | -8 | -25 | -10 | 3 |
| OPM % | 14% | 15% | 12% | 14% | 13% | 9% | -2% | 9% | 6% | -4% | -17% | -6% | 2% |
| 1 | 2 | 1 | 1 | 1 | 1 | 0 | -1 | 4 | 3 | 7 | 18 | 8 | |
| Interest | 10 | 10 | 11 | 8 | 8 | 10 | 9 | 6 | 6 | 7 | 8 | 6 | 5 |
| Depreciation | 3 | 5 | 4 | 3 | 3 | 2 | 4 | 4 | 3 | 2 | 3 | 4 | 4 |
| Profit before tax | 14 | 17 | 9 | 16 | 17 | 6 | -16 | 10 | 10 | -15 | -30 | -2 | 2 |
| Tax % | 18% | 29% | 12% | 25% | 28% | 11% | -34% | 28% | 25% | -29% | -30% | 2% | |
| 12 | 12 | 8 | 12 | 12 | 5 | -11 | 7 | 8 | -11 | -21 | -2 | 1 | |
| EPS in Rs | 32.91 | 33.91 | 22.25 | 33.82 | 33.27 | 13.82 | -25.90 | 15.46 | 16.67 | -23.29 | -44.90 | -5.39 | 1.22 |
| Dividend Payout % | 8% | 9% | 13% | 12% | 12% | 11% | -0% | 10% | 9% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -2% |
| 3 Years: | -13% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -10% |
| 3 Years: | % |
| TTM: | 107% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -11% |
| 3 Years: | -7% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -5% |
| 3 Years: | -13% |
| Last Year: | -14% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 43 | 54 | 61 | 73 | 83 | 86 | 107 | 131 | 137 | 126 | 105 | 103 | 110 |
| 52 | 58 | 58 | 36 | 46 | 55 | 37 | 26 | 32 | 40 | 32 | 3 | 0 | |
| 124 | 120 | 123 | 162 | 169 | 119 | 110 | 147 | 171 | 160 | 163 | 187 | 151 | |
| Total Liabilities | 223 | 236 | 246 | 273 | 302 | 264 | 258 | 308 | 345 | 331 | 305 | 297 | 266 |
| 34 | 30 | 27 | 38 | 36 | 34 | 36 | 33 | 31 | 29 | 32 | 19 | 34 | |
| CWIP | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 10 | 17 | 18 | -0 |
| Investments | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 23 | 19 | 51 | 57 | 98 | 75 |
| 188 | 205 | 219 | 236 | 266 | 230 | 223 | 252 | 295 | 241 | 200 | 162 | 157 | |
| Total Assets | 223 | 236 | 246 | 273 | 302 | 264 | 258 | 308 | 345 | 331 | 305 | 297 | 266 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35 | -5 | 13 | 34 | -0 | 2 | 25 | 21 | -1 | 13 | 37 | 3 | |
| -0 | -1 | 1 | -2 | -1 | -0 | 0 | -22 | 5 | -40 | -15 | 32 | |
| -25 | -5 | -12 | -31 | 1 | -2 | 1 | -4 | -1 | 1 | -22 | -34 | |
| Net Cash Flow | 11 | -10 | 1 | 1 | -1 | 0 | 27 | -5 | 4 | -26 | -1 | 1 |
| Free Cash Flow | 35 | -6 | 12 | 31 | -2 | 2 | 25 | 20 | -2 | 2 | 24 | 72 |
| CFO/OP | 141% | -3% | 67% | 144% | 12% | 24% | -622% | 103% | 12% | -163% | -145% | -42% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 121 | 151 | 160 | 174 | 195 | 140 | 131 | 125 | 154 | 127 | 129 | 96 |
| Inventory Days | 408 | 393 | 432 | 537 | 592 | 612 | 379 | 434 | 437 | 489 | 455 | 301 |
| Days Payable | 223 | 236 | 267 | 403 | 412 | 330 | 199 | 313 | 351 | 337 | 338 | 387 |
| Cash Conversion Cycle | 305 | 309 | 326 | 308 | 376 | 421 | 312 | 247 | 240 | 278 | 246 | 9 |
| Working Capital Days | 19 | 64 | 97 | 63 | 72 | 109 | 86 | 73 | 91 | 51 | -44 | -139 |
| ROCE % | 24% | 26% | 17% | 21% | 20% | 11% | -5% | 13% | 9% | -5% | -14% | -7% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of R&D Facilities Count |
|
||||||||||
| R&D Expenditure INR Lacs |
|||||||||||
| Number of permanent employees Count |
|||||||||||
| Export revenue contribution INR Lacs |
|||||||||||
| Number of distributors Count |
|||||||||||
| Number of Multi-location Trial Centers Count |
|||||||||||
| Export revenue contribution Percentage |
|||||||||||
| Number of new hybrids launched Count |
|||||||||||
| Number of retailers Count |
|||||||||||
| Number of scientists Count |
|||||||||||
Requires Premium
Requires Premium
Documents
Announcements
- Closure of Trading Window 26 Mar
-
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
6 Mar - JKAGL stake in JKARSL reduced from 49% to 8.16%; JKARSL no longer associate (5 Mar 2026).
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
3 Mar - Newspaper Publication regarding opening of Special Window for transfer and dematerialisation of physical securities that were sold/purchased prior to 1st April 2019.
-
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015
4 Feb - Section 11 application filed Feb 3, 2026 seeking arbitrator for Rs.61.23 Lakh advance; claim Rs.64.43 Lakh.
- Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Nine Months Ended 31St December 2025 4 Feb
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
JKAGL is a part of JK Group. It is in the research and development, production, processing, and marketing of Field Crops, Cotton, Vegetables, Plant Nutrition, etc. Company sells products under the brand name JK Seeds